Albert David (NSE:ALBERTDAVD) Research & Development: ₹0 Mil (TTM As of Mar. 2026)


NSE:ALBERTDAVD Albert David Ltd NSE:ALBERTDAVD
74 GF Score
Price ₹719.60
GF Value ₹830.17
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Albert David Research & Development?

Albert David NSE:ALBERTDAVD +0.60% 74 Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:ALBERTDAVD with a GF Score™ of 74/100 and a GF Value™ of ₹830.17 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Albert David's Research & Development for the three months ended in Mar. 2026 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Albert David  (NSE:ALBERTDAVD) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Albert David Research & Development Related Terms

Albert David Research & Development Historical Data

* Premium members only.

The historical data trend for Albert David's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Albert David Research & Development Chart

Albert David Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.01 18.96 19.49 28.92 0.00

Albert David Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:ALBERTDAVD
74GF Score
Albert David Ltd NSE:ALBERTDAVD
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Albert David Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
Albert David (NSE:ALBERTDAVD) has a Research & Development of ₹0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Albert David and its competitors.
Is Albert David's Research & Development too high?
Albert David's current Research & Development is ₹0 Mil. Overall, Albert David has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Albert David's Research & Development compare to ZTS and UTHR?
Albert David's Research & Development of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Albert David and its competitors. Albert David's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Albert David stock overvalued right now?
Based on GuruFocus' analysis, Albert David (NSE:ALBERTDAVD) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹830.17, compared to a current price of ₹719.60 — trading 13.3% below its estimated fair value. The current Research & Development is ₹0 Mil. Albert David's overall GF Score™ is 74/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Albert David (NSE:ALBERTDAVD), the current Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Albert David (NSE:ALBERTDAVD) Overvalued in 2026?

Based on GuruFocus' analysis, Albert David stock appears to be undervalued. The current stock price of ₹719.60 is trading 13.3% below its estimated GF Value™ of ₹830.17. GuruFocus considers Albert David to be Modestly Undervalued.

Key valuation signals for NSE:ALBERTDAVD:

  • Research & Development: ₹0 Mil
  • GF Value™: ₹830.17 vs. price of ₹719.60 (13.3% below fair value)
  • GF Score™: 74/100 with 2 warning signs

No single metric tells the full story. See the NSE:ALBERTDAVD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Albert David Business Description

Other Exchanges 524075:India
Address 8, Netaji Subhas Road, D-Block, 3rd Floor, Gillander House, Kolkata, WB, IND, 700001
Albert David Ltd is engaged in the manufacturing and trading of pharmaceutical products. The company offers products such as pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Its formulation product covers parenteral, oral, enteral, topical agents, and vision care solutions. The company exports its product to regions like Latin America, Southeast Asia, and a few African countries. The Company is only engaged in the manufacturing of pharmaceutical products, ipso facto, one reportable segment.
74GF Score

Get the complete analysis for NSE:ALBERTDAVD

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹719.60
Price
₹830.17
GF Value